At a Glance
"Continuous, dynamic growth."
"Culture, coworkers, variety of work."
"Science focus and flexibility."
"Business support services."
"Demand for services exceeds supply."
"The deadline pressure."
"Well reputed within their niche field but a very different type of 'consulting' than a Bain or BCG would provide."
"If you want a health economic model to submit to NICE, they may be your guys."
About Evidera, Inc.
Evidera provides evidence, value, and insight for clients through health economics, outcomes research, market access, data analytics, and epidemiology research and consulting services. The company partners with life science organizations worldwide, leveraging expert knowledge of the global payer and regulatory landscape to help generate and communicate evidence of product value to inform decision making and optimize the commercial potential of their products.
With almost 500 employees representing over 40 nationalities across eight major office locations in North America and Europe, Evidera's talent pool is fully stocked with experts: a substantial number of its scientific and consulting staff have more than 15 years of experience, and approximately two-thirds hold advanced degrees. Evidera scientists have published over 2,200 peer-reviewed articles, and average over 200 research posters and other presentations each year.
Innovation is a core value at Evidera, and serves as the foundation for the company's capabilities and solutions. Evidera has a history of developing innovative approaches for technology-enabled data analytics, new methods for modeling and simulation, and has also led the development of the first consortium-developed patient reported outcomes (PRO) instrument (the EXACT-PRO) to receive qualification statements from both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA). Evidera continues to invest in the development of new solutions, including: Evalytica®, a cloud-based software platform for fast, transparent analysis of healthcare data, interactive global value dossiers, and numerous new capabilities in statistical analyses and advanced modeling (e.g., Discretely Integrated Condition Event (DICE) simulation, Multi-Criteria Decision Analysis (MCDA), Simulated Treatment Comparisons (STC), Matching Adjusted Indirect Comparisons (MAIC)).
Evidera has a track record of successful interactions with payers and health authorities in many markets (e.g., FDA, EDA, NICE, GBA), and they maintain one of the largest networks of payers and HTA bodies in the world, allowing for rapid, relevant payer input on behalf of clients.
Evidera was formed in 2013 and was acquired by Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), in September, 2016. Evidera maintains over 30 years of leadership and experience through its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group and Archimedes.
7101 Wisconsin Avenue, Suite 1400
Bethesda, MD 20814
Phone: (301) 654-9729
Employer Type: Private
President: Jon N. Williams
2017 Employees (All Locations): 500
San Francisco, CA
Global Market Access
Real World Evidence
Patient Centered/Outcomes Research
Modeling & Simulation
Market Access Communications
Market Access Consulting
Medical Writing and Healthcare Communications
Precision and Transformative Technology Solutions